Are you Dr. Wallis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Saunders Hollow Rd
Old Lyme, CT 06371Phone+1 860-598-9160
Summary
- Dr. Robert Wallis, MD is an infectious disease specialist in Old Lyme, Connecticut. He is currently licensed to practice medicine in Connecticut, District of Columbia, and New Jersey.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1986 - 1987
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1984 - 1986
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1982 - 1984
- Case Western Reserve University School of MedicineClass of 1982
Certifications & Licensure
- CT State Medical License 2010 - 2024
- DC State Medical License 2008 - 2013
- NJ State Medical License 2000 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- The Effects of Prednisone on HIV Levels and the Immune System Start of enrollment: 1996 Aug 01
Publications & Presentations
PubMed
- 178 citationsHigh-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trialMartin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse, Andreas H. Diacon, Rodney Dawson
The Lancet. Infectious Diseases. 2017-01-01 - 217 citationsHost-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S. Wallis, Stefan H. E. Kaufmann, Roxana Rustomjee
The Lancet. Infectious Diseases. 2016-04-01 - 181 citationsImmunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D. Simmons, Catherine M. Stein, Chetan Seshadri, Monica Campo, Galit Alter
Nature Reviews. Immunology. 2018-09-01
Grant Support
- Antigenuria--Experimental &Human Mycobacterial InfectNational Institute Of Allergy And Infectious Diseases2000
- Antigenuria--Experimental &Human Mycobacterial InfectNational Institute Of Allergy And Infectious Diseases1997–1999
- Monocyte Activating MTB Proteins In TB PathogenesisNational Institute Of Allergy And Infectious Diseases1996
- Protective/Diagnostic Recombinant Mycobacterial AntigensNational Institute Of Allergy And Infectious Diseases1995
- Monocyte-Activating MTB Proteins In TB PathogenesisNational Institute Of Allergy And Infectious Diseases1993–1995
- Hybridoma Selection--Recombinant Mycobacterial AntigensNational Institute Of Allergy And Infectious Diseases1988–1992
- Recombinant Mycobacterial Antigens Selection Using MabsNational Center For Research Resources1988